Description

The metabolic syndrome (MS), which is also called insulin resistance syndrome or syndrome X is a cluster of risk factors that contribute to excessive cardiovascular disease morbidity among overweight and obese patient. Apart from the increase risk of having coronary artery disease, those with MS but without diabetes are also at risk for developing type 2 diabetes mellitus. Each component of MS leads to an increase risk of cardiovascular-related death and worsens the severity of coronary artery disease. This risk is exacerbated when metabolic syndrome is present. To date the prevalence of metabolic syndrome is increasing worldwide. Thus something must be done to overcome this health problem.